93 related articles for article (PubMed ID: 19487967)
1. Discordance of molecular biomarkers associated with epidermal growth factor receptor pathway between primary tumors and lymph node metastasis in non-small cell lung cancer.
Park S; Holmes-Tisch AJ; Cho EY; Shim YM; Kim J; Kim HS; Lee J; Park YH; Ahn JS; Park K; Jänne PA; Ahn MJ
J Thorac Oncol; 2009 Jul; 4(7):809-15. PubMed ID: 19487967
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancer.
Xu CW; Wang WX; Wu MJ; Zhu YC; Zhuang W; Lin G; Du KQ; Huang YJ; Chen YP; Chen G; Fang MY
Thorac Cancer; 2017 Sep; 8(5):417-422. PubMed ID: 28590585
[TBL] [Abstract][Full Text] [Related]
3. Implications of ZNF334 gene in lymph node metastasis of lung SCC: potential bypassing of cellular senescence.
Khashei Varnamkhasti K; Moghanibashi M; Naeimi S
J Transl Med; 2024 Apr; 22(1):372. PubMed ID: 38637790
[TBL] [Abstract][Full Text] [Related]
4. Association of predicted pathogenic mutations in mitochondrial ND genes with distant metastasis in NSCLC and colon cancer.
Koshikawa N; Akimoto M; Hayashi JI; Nagase H; Takenaga K
Sci Rep; 2017 Nov; 7(1):15535. PubMed ID: 29138417
[TBL] [Abstract][Full Text] [Related]
5. Concurrent somatic mutations in driver genes were significantly correlated with lymph node metastasis and pathological types in solid tumors.
Cheng Y; Wang S; Han L; Liu P; Li H; Ren X; Yu J; Hao X
Oncotarget; 2017 Sep; 8(40):68746-68757. PubMed ID: 28978153
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry combined with NGS to assist the differential diagnosis of multiple primary lung cancer with lymph node metastasis: a case report.
Liu C; Zhang S; Yang H; Bai Y; Shen Y; Ren Y
Front Oncol; 2023; 13():1260759. PubMed ID: 37920154
[TBL] [Abstract][Full Text] [Related]
7. Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial.
Wu YL; Cheng Y; Zhou J; Lu S; Zhang Y; Zhao J; Kim DW; Soo RA; Kim SW; Pan H; Chen YM; Chian CF; Liu X; Tan DSW; Bruns R; Straub J; Johne A; Scheele J; Park K; Yang JC;
Lancet Respir Med; 2020 Nov; 8(11):1132-1143. PubMed ID: 32479794
[TBL] [Abstract][Full Text] [Related]
8. Intratumor heterogeneity comparison among different subtypes of non-small-cell lung cancer through multi-region tissue and matched ctDNA sequencing.
Zhang Y; Chang L; Yang Y; Fang W; Guan Y; Wu A; Hong S; Zhou H; Chen G; Chen X; Zhao S; Zheng Q; Pan H; Zhang L; Long H; Yang H; Wang X; Wen Z; Wang J; Yang H; Xia X; Zhao Y; Hou X; Ma Y; Zhou T; Zhang Z; Zhan J; Huang Y; Zhao H; Zhou N; Yi X; Zhang L
Mol Cancer; 2019 Jan; 18(1):7. PubMed ID: 30626401
[TBL] [Abstract][Full Text] [Related]
9. Incidence, Correlates, and Prognostic Significance of Mixed Response in Advanced Non-small Cell Lung Cancer.
Gerber DE; Wang Y; Ramalingam SS; Bhalla S; Sun Z; Borghaei H; Brahmer JR; Schiller JH
Oncologist; 2024 Apr; 29(4):342-349. PubMed ID: 38207008
[TBL] [Abstract][Full Text] [Related]
10. Measured Steps: Navigating the Path of Oligoprogressive Lung Cancer with Targeted and Immunotherapies.
Jongbloed M; Khosla AA; Bartolomeo V; Jatwani K; Singh R; De Ruysscher DKM; Hendriks LEL; Desai A
Curr Oncol Rep; 2024 Jan; 26(1):80-89. PubMed ID: 38175464
[TBL] [Abstract][Full Text] [Related]
11. The Glasgow Prognostic Score Predicts Survival in Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations Who Are Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors.
Akazawa Y; Igawa S; Yamada K; Yamamoto H; Yagami Y; Kaizuka N; Manaka H; Kasajima M; Nakahara Y; Sato T; Mitsufuji H; Yokoba M; Kubota M; Sasaki J; Naoki K
Oncology; 2023; 101(11):685-694. PubMed ID: 37166346
[TBL] [Abstract][Full Text] [Related]
12. FACILITATE: A real-world, multicenter, prospective study investigating the utility of a rapid, fully automated real-time PCR assay versus local reference methods for detecting epidermal growth factor receptor variants in NSCLC.
Behnke A; Cayre A; De Maglio G; Giannini G; Habran L; Tarsitano M; Chetta M; Cappellen D; Lespagnol A; Le Naoures C; Massazza G; Destro A; Bonzheim I; Rau A; Battmann A; Kah B; Watkin E; Hummel M
Pathol Oncol Res; 2023; 29():1610707. PubMed ID: 36798672
[TBL] [Abstract][Full Text] [Related]
13. Molecular Features in Lymphatic Metastases Reflect the Metastasis Mechanism of Lymph Nodes With Non-Small-Cell Lung Cancers.
Guo N; Chen Y; Jing Z; Liu S; Su J; Li R; Duan X; Chen Z; Chen P; Yin R; Li S; Tang J
Front Bioeng Biotechnol; 2022; 10():909388. PubMed ID: 35923575
[TBL] [Abstract][Full Text] [Related]
14. Co-occurrence CDK4/6 amplification serves as biomarkers of de novo EGFR TKI resistance in sensitizing EGFR mutation non-small cell lung cancer.
Sitthideatphaiboon P; Teerapakpinyo C; Korphaisarn K; Leelayuwatanakul N; Pornpatrananrak N; Poungvarin N; Chantranuwat P; Shuangshoti S; Aporntewan C; Chintanapakdee W; Sriuranpong V; Vinayanuwattikun C
Sci Rep; 2022 Feb; 12(1):2167. PubMed ID: 35140316
[TBL] [Abstract][Full Text] [Related]
15. A Prospective Observational Study of Osimertinib for Chemo-Naive Elderly Patients with
Igawa S; Kasajima M; Ono T; Ozawa T; Kakegawa M; Kusuhara S; Sato T; Nakahara Y; Fukui T; Yokoba M; Kubota M; Mitsufuji H; Sasaki J; Naoki K
Cancer Manag Res; 2021; 13():8695-8705. PubMed ID: 34849025
[TBL] [Abstract][Full Text] [Related]
16. Genomic landscape of metastatic lung adenocarcinomas from large-scale clinical sequencing.
Li D; Huang Y; Cai L; Wu M; Bao H; Xu Y; Wei Y; Wu S; Wu X; Shao Y; Zhao W; Lv G; Huang S; Zhang T; Shi Y
Neoplasia; 2021 Dec; 23(12):1204-1212. PubMed ID: 34735995
[TBL] [Abstract][Full Text] [Related]
17. Identifying Lung Cancer Cell Markers with Machine Learning Methods and Single-Cell RNA-Seq Data.
Huang GH; Zhang YH; Chen L; Li Y; Huang T; Cai YD
Life (Basel); 2021 Sep; 11(9):. PubMed ID: 34575089
[TBL] [Abstract][Full Text] [Related]
18. A narrative review on tumor microenvironment in oligometastatic and oligoprogressive non-small cell lung cancer: a lot remains to be done.
Belluomini L; Dodi A; Caldart A; Kadrija D; Sposito M; Casali M; Sartori G; Ferrara MG; Avancini A; Bria E; Menis J; Milella M; Pilotto S
Transl Lung Cancer Res; 2021 Jul; 10(7):3369-3384. PubMed ID: 34430373
[TBL] [Abstract][Full Text] [Related]
19. Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer.
Rashdan S; Iyengar P; Minna JD; Gerber DE
Transl Lung Cancer Res; 2021 Jul; 10(7):3351-3368. PubMed ID: 34430372
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
